DENYES NANCY 4
4 · aTYR PHARMA INC · Filed Jan 9, 2026
Insider Transaction Report
Form 4
aTYR PHARMA INCATYR
DENYES NANCY
General Counsel
Transactions
- Award
Employee Stock Options (right to buy)
2026-01-09+412,500→ 412,500 totalExercise: $0.71Exp: 2036-01-09→ Common Stock (412,500 underlying)
Holdings
- 31,555
Common Stock
Footnotes (2)
- [F1]Includes 2,500 shares acquired on May 15, 2025 and 2,500 shares acquired on November 14, 2025 under the Company's 2015 Employee Purchase Plan.
- [F2]The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning February 9, 2026, such that this option will be fully exercisable on January 9, 2029. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.